Category: Neurology

Erenumab for preventing migraine

This is a new guideline from NICE advising that erenumab can be used for the prevention of migraine, published in March 2020.

Galcanezumab for the prevention of migraine

This new guideline was published in November 2020.

Fremanezumab for preventing migraine

Although fremanezumab seems to be effective in episodic migraine, it hasn't been approved as it isn't felt to be cost-effective

Cluster headaches and gammaCore

About 5 people a year in the UK commit suicide because of cluster headaches. The side-effects from conventional medications and the monitoring required can be difficult.

Stroke and TIA – initial management

This is an updated guideline from NICE on the management of stroke and TIA in over 16s. It was first published in 2008 and this update is from May 19.

e-Learning | Management of dementia

This is a new guideline from NICE on the management of dementia.

Multiple Sclerosis – Cladribine tablets (Mavenclad)

Migraine – transcutaneous electrical stimulation of the supraorbital nerve

Nice | Alzheimer’s drugs

Nice | New treatments for migraines and sinusitis

Motor neurone disease – MND

Management of multiple sclerosis

Trigeminal neuralgia

Nice | Head injury

Nice | New treatments for BPH, MS and migraine

Nice | Neuropathic pain

Nice | Stroke rehabilitation

ICDs, Occipital stimulation for Migraine and Treatment of Vertebral Fractures

Nerve stimulation in Back Pain and in Neuralgia

The Popular Arts: a Strategy for Dementia

Headaches in Young People and adults

Urinary incontinence in neurological disease

Spasticity in children

Botulinum A for migraine